These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11549101)

  • 21. Comparison between concentrations of amphotericin B in infected lung lesion and in uninfected lung tissue in a patient treated with liposomal amphotericin B (AmBisome).
    Watanabe A; Matsumoto K; Igari H; Uesato M; Yoshida S; Nakamura Y; Morita K; Shibuya K; Matsubara H; Yoshino I; Kamei K
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e220-3. PubMed ID: 19959388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodistribution and
    Iman M; Huang Z; Alavizadeh SH; Szoka FC; Jaafari MR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.
    van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA
    J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.
    Walsh TJ; Yeldandi V; McEvoy M; Gonzalez C; Chanock S; Freifeld A; Seibel NI; Whitcomb PO; Jarosinski P; Boswell G; Bekersky I; Alak A; Buell D; Barret J; Wilson W
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2391-8. PubMed ID: 9736569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D; Safdar N; Marchillo K; Conklin R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition.
    Kagan L; Gershkovich P; Wasan KM; Mager DE
    Pharm Res; 2014 Jan; 31(1):35-45. PubMed ID: 23793994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary extraction and accumulation of lipid formulations of amphotericin B.
    Matot I; Pizov R
    Crit Care Med; 2000 Jul; 28(7):2528-32. PubMed ID: 10921589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.
    Hong Y; Shaw PJ; Nath CE; Yadav SP; Stephen KR; Earl JW; McLachlan AJ
    Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma.
    Stone JA; Xu X; Winchell GA; Deutsch PJ; Pearson PG; Migoya EM; Mistry GC; Xi L; Miller A; Sandhu P; Singh R; deLuna F; Dilzer SC; Lasseter KC
    Antimicrob Agents Chemother; 2004 Mar; 48(3):815-23. PubMed ID: 14982770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel delivery system for amphotericin B with lipid nano-sphere (LNS).
    Fukui H; Koike T; Saheki A; Sonoke S; Seki J
    Int J Pharm; 2003 Oct; 265(1-2):37-45. PubMed ID: 14522116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential distribution of liposome-entrapped [3H]methotrexate and labelled lipids after intravenous injection in a primate.
    Kimelberg HK
    Biochim Biophys Acta; 1976 Nov; 448(4):531-50. PubMed ID: 823974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases.
    Hong Y; Shaw PJ; Tattam BN; Nath CE; Earl JW; Stephen KR; McLachlan AJ
    Eur J Clin Pharmacol; 2007 Feb; 63(2):165-72. PubMed ID: 17180621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and tissue distribution of a new partricin A derivative (N-dimethylaminoacetyl-partricin A 2-dimethylaminoethylamide diaspartate) in mice.
    Rimaroli C; Bonabello A; Sala P; Bruzzese T
    J Pharm Sci; 2002 May; 91(5):1252-8. PubMed ID: 11977101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of liposomal amphotericin B formulation.
    Gulati M; Bajad S; Singh S; Ferdous AJ; Singh M
    J Microencapsul; 1998; 15(2):137-51. PubMed ID: 9532520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.
    Gershkovich P; Wasan EK; Lin M; Sivak O; Leon CG; Clement JG; Wasan KM
    J Antimicrob Chemother; 2009 Jul; 64(1):101-8. PubMed ID: 19398459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of 3H-cholesteryl ether labeled liposomes following intravenous administration to mice: comparison with an encapsulated 14C-inulin as aqueous phase marker.
    Anderson M; Paradis C; Omri A
    Drug Deliv; 2003; 10(3):193-200. PubMed ID: 12944140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates.
    Kotwani RN; Gokhale PC; Bodhe PV; Kirodian BG; Kshirsagar NA; Pandya SK
    Int J Pharm; 2002 May; 238(1-2):11-5. PubMed ID: 11996806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of liposomal amphotericin B in neutropenic cancer patients.
    Eldem T; Arican-Cellat N; Agabeyoglu I; Akova M; Kansu E
    Int J Pharm; 2001 Feb; 213(1-2):153-61. PubMed ID: 11165103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
    Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
    Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antifungal pharmacodynamic characteristics of AmBisome against Candida albicans.
    Takemoto K; Yamamoto Y; Ueda Y
    Microbiol Immunol; 2006; 50(8):579-86. PubMed ID: 16924142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.